Concepedia

Andrew Lin

AL

Statistics

Publications

27

Citations

1.4K

H-Index

20

Active since

1998

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Molecular Oncology (United States)

Hôpitaux Universitaires de Strasbourg

The University of Texas MD Anderson Cancer Center

Andrew Lin is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and neuro-oncology.

ORCID

Publications per year

1998–2025

27

Publications

27

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

Christian Grommes, Sarah Tang, J. M. Wolfe et al. · Blood · 2018 · 246 citations · Full text

, , +16

Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

Philip Jonsson, Andrew Lin, Robert J. Young et al. · Clinical Cancer Research · 2019 · 156 citations · Full text

, , +17

Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab

Andrew Lin, Philip Jonsson, Viviane Tabar et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 147 citations · Full text

, , +17

Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis

Jonathan T. Yang, N. Ari Wijetunga, Elena Pentsova et al. · Journal of Clinical Oncology · 2022 · 142 citations · Full text

, , +17

Clinical trial of proton craniospinal irradiation for leptomeningeal metastases

Jonathan T. Yang, N. Ari Wijetunga, Josh Yamada et al. · Neuro-Oncology · 2020 · 101 citations · Full text

, , +17

1–5 of 27